IL10 and prostate cancer: However, to delineate the importance of IL-10 in the immunosuppressive effect mediated by MDSCs through STAT3, Hellsten and colleagues [157] have demonstrated that inhibition of STAT3 using galiellalactone prevented the generation of MDSC-like cells from treated prostate cancer ex vivo.